GeneFab offers its customers an extensive technology platform and know-how that spans early stage product design, technical development, and cGMP compliant production. GeneFab's technology platform includes bioinformatic-guided discovery of cell type promoters, directed evolution of small molecule-regulated gene switches, and the engineering of highly sensitive kill switches for enhanced safety and control of cellular therapies.
| Website | https://genefab.com |
| Revenue | $10.6 million |
| Employees | 61 (57 on RocketReach) |
| Founded | 2023 |
| Address | 1430 Harbor Bay Pkwy, Alameda, California 94502, US |
| Industry | Biotechnology Research |
| Keywords | Biotechnology, Cell Therapy, Gene Therapy, Biomanufacturing, Pharmaceutical Manufacturing, Biologics Manufacturing, Biopharmaceutical, Cell Engineering, Process Development, Technology Platform, Bioinformatics, Drug Development, Product Design, Clinical Manufacturing, Upstream Processing, Downstream Processing, Quality Control, Contract Manufacturing, Analytical Testing |
| Competitors | Thermo Fisher Scientific, Agilent Technologies, Illumina, Bio-Rad Laboratories, QIAGEN, Integrated DNA Technologies, GenScript, bluebird bio, Eurofins Genomics Americas, Bioneer +40 more (view full list) |
Looking for a particular GeneFab employee's phone or email?
The GeneFab annual revenue was $10.6 million in 2026.
Philip Lee is the CEO of GeneFab.
57 people are employed at GeneFab.
GeneFab is based in Alameda, California.